PENICILLIN BINDING PROTEINS IGF::OT::IGF

DEFINITIVE CONTRACT won by VENATORX PHARMACEUTICALS INC · work in MALVERN, PA
$14,716,733
RecipientVENATORX PHARMACEUTICALS INC UEI MBBKNBU5DCC6
Award IDHDTRA117C0070
Award amount$14,716,733
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Defense — Defense Threat Reduction Agency
NAICS541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PSCAD92
Start dateAug 28, 2017
End dateApr 30, 2022
Place of performanceMALVERN, PA
Record updatedApr 30, 2026

View the official award record

More awards won by VENATORX PHARMACEUTICALS INC

VENATORX PHARMACEUTICALS, INC.
Department of Health and Human Services · $131,756,814 · Jul 17, 2019
VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS
Department of Health and Human Services · $72,141,707 · Sep 27, 2022
IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH.
Department of Health and Human Services · $45,154,088 · Sep 19, 2016
VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.
Department of Health and Human Services · $26,449,853 · Sep 15, 2023
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Department of Health and Human Services · $10,669,276 · Jul 1, 2020

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids